Abstract
In recent years, the promise and prospects of nanomedicine have been controversially discussed. We here argue that nanomedicine has undeniably been successful, not only academically and preclinically, but also industrially and clinically. To ensure that we keep on making progress, we have to move away from over-focusing on nano and on materials, towards more holistic approaches that address real medical problems, in a realistic manner.